logo
Share SHARE
FONT-SIZE Plus   Neg

Qihoo 360 Technology Q3 Profit Tops Estimate

Qihoo 360 Technology Co. Ltd. (QIHU) reported net income for the third quarter of $12.9 million or $0.11 per ADS, compared to $10.9 million or $0.09 per ADS for the year-ago quarter.

Net income excluding share-based compensation was $24.2 million or $0.20 per ADS for the third quarter, compared to $19.5 million or $0.16 per ADS in the prior year quarter.

Revenues for the third quarter jumped 77% to $84.0 million from $47.5 million a year ago, mainly due to continued robust growth in both online advertising and Internet value-added services..

Analsts polled by Thomson Reuters expected the company to earn $0.16 per ADS on revenue of $81.59 million for the third quarter. Analysts' estimates typically exclude special items.

Looking forward, the company forecast fourth quarter revenue to be between $93 million and $94 million, representing a year-over-year increase of 49% - 51%.

For the full year 2012, the company expects revenues to be between $319 million and $320 million.

Analysts currently expect the company to post revenue of $91.29 million for the fourth quarter and $315.51 million for the full year 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT